TARSONS PRODUCTS LIMITED Financials Tarsons Products Limited
Equities
TARSONS
INE144Z01023
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 438.5 INR | -0.36% |
|
+1.32% | -16.84% |
Valuation
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 37,401 | 28,314 | 23,564 | - | - |
| Enterprise Value (EV) 1 | 36,759 | 28,820 | 23,585 | 23,739 | 24,382 |
| P/E ratio | 36.1 x | 35.1 x | 37.1 x | 25.7 x | 22.1 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 12.4 x | 10 x | 8.01 x | 6.12 x | 5.07 x |
| EV / Revenue | 12.2 x | 10.2 x | 8.02 x | 6.17 x | 5.24 x |
| EV / EBITDA | 24.1 x | 22.2 x | 20 x | 14.5 x | 12.4 x |
| EV / FCF | -75.8 x | -25.2 x | -171 x | 36.2 x | 130 x |
| FCF Yield | -1.32% | -3.97% | -0.59% | 2.76% | 0.77% |
| Price to Book | 7.42 x | 4.97 x | 3.63 x | 3.13 x | 2.89 x |
| Nbr of stocks (in thousands) | 53,206 | 53,206 | 53,738 | - | - |
| Reference price 2 | 703.0 | 532.2 | 438.5 | 438.5 | 438.5 |
| Announcement Date | 5/27/22 | 5/27/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 3,008 | 2,832 | 2,942 | 3,848 | 4,650 |
| EBITDA 1 | - | 1,527 | 1,298 | 1,179 | 1,640 | 1,959 |
| EBIT 1 | - | 1,307 | 1,013 | 798 | 1,154 | 1,342 |
| Operating Margin | - | 43.46% | 35.75% | 27.12% | 29.98% | 28.87% |
| Earnings before Tax (EBT) 1 | - | 1,350 | 1,087 | 842.2 | 1,217 | 1,418 |
| Net income 1 | 688.7 | 1,007 | 807.1 | 628.5 | 908 | 1,055 |
| Net margin | - | 33.47% | 28.5% | 21.36% | 23.6% | 22.69% |
| EPS 2 | 13.43 | 19.46 | 15.17 | 11.82 | 17.08 | 19.83 |
| Free Cash Flow 1 | - | -485 | -1,144 | -138 | 655.5 | 187 |
| FCF margin | - | -16.12% | -40.38% | -4.69% | 17.03% | 4.02% |
| FCF Conversion (EBITDA) | - | - | - | - | 39.98% | 9.54% |
| FCF Conversion (Net income) | - | - | - | - | 72.19% | 17.72% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/6/21 | 5/27/22 | 5/27/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 849.4 | 686.3 | 712.5 | 613.2 | 625.7 | 669 | 670.5 | 901.7 |
| EBITDA 1 | 443.4 | 311.4 | 326.9 | 266.8 | 213 | 253 | 253 | 340.7 |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | 392.2 | 272.6 | - | 215.9 | 128.5 | - | - | 179 |
| Net income 1 | 294.6 | 203.1 | - | 161.2 | 95.96 | 141 | 136 | 166.5 |
| Net margin | 34.69% | 29.59% | - | 26.28% | 15.34% | 21.08% | 20.28% | 18.47% |
| EPS 2 | 5.570 | 3.820 | - | - | 1.800 | - | - | 2.600 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 5/27/22 | 8/6/22 | 11/5/22 | 2/12/23 | 8/11/23 | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 507 | 21 | 175 | 818 |
| Net Cash position 1 | - | 642 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 0.3905 x | 0.0178 x | 0.1067 x | 0.4175 x |
| Free Cash Flow 1 | - | -485 | -1,144 | -138 | 656 | 187 |
| ROE (net income / shareholders' equity) | - | 27.4% | 15.2% | 10.1% | 13% | 14% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 94.80 | 107.0 | 121.0 | 140.0 | 152.0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 1,320 | 1,900 | 1,266 | 656 | 696 |
| Capex / Sales | - | 43.87% | 67.07% | 43.01% | 17.05% | 14.97% |
| Announcement Date | 8/6/21 | 5/27/22 | 5/27/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
440.1
INR
Average target price
649
INR
Spread / Average Target
+47.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.84% | 283M | |
| -4.67% | 12.33B | |
| -5.19% | 8.14B | |
| +30.65% | 5.62B | |
| -8.09% | 4.24B | |
| -54.63% | 3.06B | |
| +13.49% | 2.76B | |
| -1.34% | 2.41B | |
| +32.24% | 2.23B | |
| -3.55% | 1.87B |
- Stock Market
- Equities
- TARSONS Stock
- Financials Tarsons Products Limited